{"disease":{"id":"thalassemia","name":"thalassemia"},"drugs":{"marketed":[{"drug_id":"luspatercept","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reblozyl","generic_name":"LUSPATERCEPT","company_name":"Celgene Corp","drug_phase":"marketed","molecular_target":"Growth/differentiation factor 11","drug_class":"Erythroid Maturation Agent [EPC]","quality_score":60,"revenue":"2327","mechanism":"Reblozyl works by binding to growth/differentiation factor 11, promoting the maturation of red blood cells."},{"drug_id":"reblozyl","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Reblozyl","company_name":"EuroBloodNet Association","drug_phase":"marketed","molecular_target":"Growth/differentiation factor 11, Growth/differentiation factor 8","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"exjade","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Exjade","company_name":"DisperSol Technologies, LLC","drug_phase":"marketed","molecular_target":"Flavin reductase (NADPH), Lysine-specific demethylase 5A","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"luspatercept-aamt","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"REBLOZYL","generic_name":"LUSPATERCEPT-AAMT","company_name":"CELGENE CORP","drug_phase":"marketed","molecular_target":"Growth/differentiation factor 11, Growth/differentiation factor 8","drug_class":"Erythroid Maturation Agent [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"deferasirox","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exjade","generic_name":"DEFERASIROX","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Flavin reductase (NADPH)","drug_class":"Iron Chelator [EPC]","quality_score":10,"revenue":null,"mechanism":"Exjade works by binding to iron in the body and removing it through the urine."},{"drug_id":"deferiprone","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ferriprox","generic_name":"DEFERIPRONE","company_name":"Chiesi","drug_phase":"marketed","molecular_target":"Deoxyhypusine hydroxylase","drug_class":"Iron Chelator [EPC]","quality_score":75,"revenue":null,"mechanism":"Ferriprox works by binding to iron in the body and removing it, thereby reducing iron overload."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT04918056","title":"Genetic Variants Affecting the Clinical Severity of Beta Thalassemia","phase":"","overall_status":"UNKNOWN","enrollment_count":1300,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04929574","title":"Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04917978","title":"Association of Hb F Level With Clinical Severity of Beta Thalassemia","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04706585","title":"Thalassemia Knowledge in Young People of Indonesia","phase":"","overall_status":"UNKNOWN","enrollment_count":1010,"lead_sponsor_name":"Fakultas Kedokteran Universitas Indonesia","has_results":false},{"nct_id":"NCT06539169","title":"FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT04009525","title":"Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":823,"lead_sponsor_name":"First Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT03687567","title":"A Retrospective Study on the Effect of HBA or HBB Genetic Defects on Early Embryonic Development","phase":"","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Reproductive & Genetic Hospital of CITIC-Xiangya","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT04064060","title":"A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":665,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT03651102","title":"Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":654,"lead_sponsor_name":"Blood Diseases Clinic","has_results":false},{"nct_id":"NCT06153784","title":"Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":603,"lead_sponsor_name":"Children's Hospital Karachi","has_results":false},{"nct_id":"NCT06609226","title":"A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03374111","title":"Colla Corii Asini Treating Anemia in Pregnant Women With Thalassemia(Presenting the Syndrome of Blood Deficiency)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":480,"lead_sponsor_name":"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04515680","title":"Endocrine Function During Deferasirox Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":426,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT01913548","title":"Multi-Center Study of Iron Overload: Survey Study (MCSIO)","phase":"","overall_status":"COMPLETED","enrollment_count":423,"lead_sponsor_name":"UCSF Benioff Children's Hospital Oakland","has_results":false},{"nct_id":"NCT06657391","title":"Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":396,"lead_sponsor_name":"Rongrong Liu","has_results":false},{"nct_id":"NCT04090268","title":"Precision Exercise in Children With Malignant Hemopathies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT06931912","title":"Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":369,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT03947632","title":"Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia","phase":"","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT02692872","title":"Screening for Alpha Thalassemia in Healthy Volunteers","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":367,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06875219","title":"To Evaluate Long- Term Safety and Efficacy of Luspatercept","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":350,"lead_sponsor_name":"Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia","has_results":false},{"nct_id":"NCT04292314","title":"Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT05508932","title":"Atrial Fibrillation in Beta-Thalassemia","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT02604433","title":"An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT03937817","title":"Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02386800","title":"CINC424A2X01B Rollover Protocol","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":279,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04310059","title":"Effect of Folic Acid Supplementation in Pregnant Women Having Thalassaemia Trait","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06026839","title":"Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03161899","title":"Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03462784","title":"Complications in Children With B- Thalassemia Major","phase":"","overall_status":"UNKNOWN","enrollment_count":201,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07215975","title":"A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06146478","title":"Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Blood Care Clinic","has_results":false},{"nct_id":"NCT06568926","title":"Adherence of Beta Thalssemia Patients to Oral Chelation Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06210139","title":"Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia","phase":"","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Reem Ali Shaker","has_results":false},{"nct_id":"NCT04973280","title":"Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT06509581","title":"Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05469230","title":"Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT03715972","title":"Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia","phase":"","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Children's Hospital Los Angeles","has_results":false},{"nct_id":"NCT04208529","title":"A Long-term Follow-up Study in Participants Who Received CTX001","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT02904252","title":"The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT05255445","title":"Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Westat","has_results":false},{"nct_id":"NCT00001203","title":"Deferoxamine for the Treatment of Hemochromatosis","phase":"","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07352878","title":"Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Elpen Pharmaceutical Co. Inc.","has_results":false},{"nct_id":"NCT07292259","title":"Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Pakistan Blood and Marrow Transplant (PBMT) Group","has_results":false},{"nct_id":"NCT06440603","title":"EKLF Gene Expression in β-thalassemia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Rofaida Hassan Ahmed","has_results":false},{"nct_id":"NCT06601556","title":"Psychiatric Problems in Thalassemic Children","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06800495","title":"Development of THALEA Kit and Its Impact on Knowledge, Attitude, and Intention for Premarital Thalassemia Screening","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":148,"lead_sponsor_name":"Universiti Teknologi Mara","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}